In line with that, stimulation of SPHK1, with the selective activator K6PC-5, exerts beneficial effects and pro-survival actions in in vitro models of HD, and importantly also in human iPSC-derived neurons from HD patients (Di Pardo et al., 2017a). Here, SPHK1 is linked to Huntington disease.